PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.25) by 40 percent. This is unchanged from the same period last year. The company reported quarterly sales of $112.00 thousand which missed the analyst consensus estimate of $270.00 thousand by 58.52 percent. This is a 62.67 percent decrease over sales of $300.00 thousand the same period last year.
SEC Charges 11 People In $300M Crypto Ponzi Scheme
The Securities and Exchange Commission has charged 11 people for their roles in creating and promoting an allegedly fraudulent crypto-focused…
